AIDS Epidemiology Group, Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand.
HIV Med. 2012 Mar;13(3):182-9. doi: 10.1111/j.1468-1293.2011.00959.x. Epub 2011 Nov 3.
Early diagnosis of HIV infection is important for the individual and for disease control. A consensus was recently reached among European countries on definitions of timing of presentation for care: 'Late presentation' refers to entering care with a CD4 count <350 cells/μL or an AIDS-defining event, regardless of the CD4 count. Presentation with 'advanced HIV disease' is a subset having a CD4 count <200 cells/μL and also includes all who have an AIDS-defining event regardless of CD4 count. This study examines timing of presentation in New Zealand from 2005 to 2010.
Since 2005, information on the initial CD4 cell count has been requested on all people newly diagnosed with HIV infection through antibody testing in New Zealand. Excluded in this analysis were those previously diagnosed overseas or for an immigration medical.
A CD4 cell count was provided for 606 (80.3%) of the 755 newly diagnosed adults. Overall, 50.0% were 'late presenters' and 32.0% had 'advanced HIV disease'. Compared with men who have sex with men (MSM), people heterosexually infected were more likely to present late. 'Late presentation' and presentation with 'advanced HIV disease' were significantly more common among older MSM. Māori and Pacific MSM were more likely to present with 'advanced HIV disease'. Compared with European MSM, the age-adjusted relative risks for Māori and Pacific MSM were 2.1 [95% confidence interval (CI) 1.4-3.2] and 2.5 (95% CI 1.2-5.0), respectively.
The high proportion of people presenting late reflects inadequate levels of HIV testing. The lower proportion of late presentations among MSM compared with those heterosexually infected may be explained by a higher proportion of recent locally acquired infections together with different testing patterns.
艾滋病病毒感染的早期诊断对个人和疾病控制都很重要。最近,欧洲各国就护理就诊时间的定义达成共识:“晚期就诊”是指 CD4 计数<350 个/μL 或出现艾滋病定义性事件时就诊,无论 CD4 计数如何。“晚期艾滋病病毒感染就诊”是指 CD4 计数<200 个/μL 的亚组,也包括所有无论 CD4 计数如何出现艾滋病定义性事件的人。本研究检查了 2005 年至 2010 年新西兰的就诊时间。
自 2005 年以来,新西兰所有通过抗体检测新诊断出艾滋病病毒感染的人都要求提供初始 CD4 细胞计数信息。本分析排除了那些在海外或移民体检时已被诊断出的人。
在 755 名新诊断的成年艾滋病病毒感染者中,有 606 人(80.3%)提供了 CD4 细胞计数。总体而言,50.0%为“晚期就诊者”,32.0%为“晚期艾滋病病毒感染就诊者”。与男男性行为者(MSM)相比,异性恋感染者更有可能晚期就诊。老年 MSM 中“晚期就诊”和“晚期艾滋病病毒感染就诊”更为常见。毛利人和太平洋岛民 MSM 更有可能出现“晚期艾滋病病毒感染”。与欧洲 MSM 相比,毛利和太平洋岛民 MSM 的年龄调整相对风险分别为 2.1(95%置信区间(CI)为 1.4-3.2)和 2.5(95% CI 1.2-5.0)。
大量人晚期就诊反映了艾滋病病毒检测水平不足。与异性恋感染者相比,MSM 中晚期就诊者的比例较低,这可能是由于最近本地获得的感染比例较高以及不同的检测模式所致。